Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vTv Therapeutics
Biotech
FDA puts vTv's diabetes drug on hold over chromatographic signal
The FDA has placed vTv’s phase 3 trial for cadisegliatin on hold, two years after the biotech stacked its remaining chips on the Type 1 diabetes drug.
James Waldron
Jul 29, 2024 4:47am
New federal biotech commission taps 12 members—Chutes & Ladders
Feb 3, 2023 10:20am
Amgen vet to be CMO at Affini-T—Chutes & Ladders
Jul 29, 2022 9:30am
vTv CEO resigns four months in and board member takes over
Mar 4, 2022 9:50am
Athira CEO resigns after investigation—Chutes & Ladders
Oct 22, 2021 9:30am
vTv's Alzheimer's drug azeliragon flops in phase 3 again
Jun 13, 2018 10:24am